[ Trusted Worldwide ]
          Graviti’s International Business division delivers high-quality, compliant pharmaceutical products globally through strategic partnerships and regulatory excellence. With filings underway in the UK and Europe, and world-class manufacturing aligned with USFDA and WHO-GMP standards, we ensure agile development and seamless commercialization—advancing healthcare access and value across borders.
          
          Our generics are manufactured in state-of-the-art facilities that comply with USFDA, WHO-GMP, and other stringent regulatory authorities, ensuring safety, efficacy, and quality at every step.
          We offer a broad portfolio of generics across key therapeutic areas—Cardiovascular, Diabetes, Antibiotics, CNS (Central Nervous System), and more—addressing major global health challenges.
Cardiovascular – Advanced therapies for heart health 
            Diabetes – Effective solutions for glycemic control 
Antibiotics – Combatting bacterial infections
            
CNS (Central Nervous System) – Treatments for neurological and psychiatric conditions
          Through continuous innovation and investment in research, we develop bioequivalent generics that meet the highest standards of quality, stability, and therapeutic effectiveness.